EGFR-mutant NSCLC may remodel TME from non-inflamed to inflamed through acquiring resistance to EGFR-TKI treatment
Qianqian Chen, Liliang Xia, Jingze Wang, Shuxin Zhu, Jing Wang, Xing Li, Yongfeng Yu, Ziming Li, Ying Wang, Guanshan Zhu, Shun Lü
Topics & Concepts
MedicineLung cancerGranzyme BImmunotherapyT790MOncologyPD-L1Epidermal growth factor receptorInternal medicineCancer researchProinflammatory cytokineImmune systemImmunologyCancerT cellGefitinibInflammationCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsFerroptosis and cancer prognosis